Company Name: |
BOC Sciences
|
Tel: |
1-631-485-4226; 16314854226 |
Email: |
info@bocsci.com |
Products Intro: |
Product Name:RE-0004090 (PS360814) CAS:254737-96-7 Purity:> 95% Remarks:An impurity of sparsentan. Sparsentan could be the first FDA-approved pharmacologic treatment for fo
|
Company Name: |
BOC Sciences
|
Tel: |
16314854226 |
Email: |
info@bocsci.com |
Products Intro: |
Product Name:RE-0004090 (PS360814) CAS:254737-96-7 Purity:>95%
|
|
| RE-0004090 (PS360814) Basic information |
Product Name: | RE-0004090 (PS360814) | Synonyms: | RE-0004090 (PS360814);[1,1'-Biphenyl]-2-sulfonamide, 4'-[(2-butyl-4-oxo-1,3-diazaspiro[4.4]non-1-en-3-yl)methyl]-N-(4,5-dimethyl-3-isoxazolyl)-2'-formyl- | CAS: | 254737-96-7 | MF: | C30H34N4O5S | MW: | 562.68 | EINECS: | | Product Categories: | | Mol File: | 254737-96-7.mol | |
| RE-0004090 (PS360814) Chemical Properties |
Boiling point | 757.2±70.0 °C(Predicted) | density | 1.33±0.1 g/cm3(Predicted) | pka | 7.03±0.50(Predicted) |
| RE-0004090 (PS360814) Usage And Synthesis |
| RE-0004090 (PS360814) Preparation Products And Raw materials |
|